Structure and function of α-fetoprotein: A biophysical overview

Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology

Volumn 1480, Issue 1-2, 2000, Pages 41-56

  Gillespie, Joel R ^a   Uversky, Vladimir N ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUTE FOR BIOLOGICAL INSTRUMENTATION   (Russian Federation)

Author keywords

Conformational stability; Protein conformation; Protein denaturation; Protein structural property; Structure function relationship; Fetoprotein

Indexed keywords

ALPHA FETOPROTEIN;

CONFORMATIONAL TRANSITION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION; THERMODYNAMICS;

EID: 0034647647     PISSN: 01674838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4838(00)00104-7     Document Type: Article

References (120)

1. Bergstrand C.G., Czar B. Demonstration of a new protein fraction in serum from the human fetus. Scand. J. Clin. Lab. Invest. 8:1956;174.
2. Ruoslahti E., Seppälä M. α-Foetoprotein in normal human serum. Nature. 235:1972;161-162.
3. Morinaga T., Sakai M., Wegmann G., Tamaoki T. Primary structure of human α-fetoprotein and mRNA. Proc. Natl. Acad. Sci. USA. 80:1983;4604-4608.
4. Deutsch H.F. Chemistry and biology of α-fetoprotein. Adv. Cancer Res. 56:1991;253-312.
5. Seppälä M., Ruoslahti E. Alpha fetoprotein: physiology and pathology during pregnancy and application to antenatal diagnosis. J. Perinat. Med. 1:1973;104-113.
6. Brock D.J., Scrimgeour J.B., Nelson M.M. Amniotic fluid alphafetoprotein measurements in the early prenatal diagnosis of central nervous system disorders. Clin. Genet. 7:1975;163-169.
7. Seppälä M. Fetal pathophysiology of human alpha-fetoprotein. Ann. New York Acad. Sci. 259:1975;59-73.
8. Ruoslahti E. alpha-Fetoprotein in cancer and fetal development. Adv. Cancer Res. 29:1979;275-346.
9. Abelev G.I. α-Fetoprotein in ontogenesis and its assosiation with malignant tumors. Adv. Cancer Res. 14:1971;295-358.
10. Okuda K., Kotoda K., Obata H., Hayashi N., Hisamitsu T. Clinical observations during a relatively early stage of hepatocellular carcinoma, with special reference to serum alpha-fetoprotein levels. Gastroenterology. 69:1975;226-234.
11. Yoshiki T., Itoh T., Shirai T., Noro T., Tomino Y., HamaJima T.I. Primary intracranial yolk sac tumor immunofluorescent demonstration of alpha-fetoprotein synthesis. Cancer. 37:1976;2343-2348.
12. Soloff M.S., Swartz S.K., Pearlmutter F., Kithier K. Binding of 17-beta-estradiol by variants of alpha-fetoprotein in rat amniotic fluid. Biochim. Biophys. Acta. 427:1972;644-651.
13. Uriel J., de Nechaud B., Dupiers M. Estrogen-binding properties of rat, mouse and man fetospecific serum proteins. Demonstration by immuno-autoradiographic methods. Biochem. Biophys. Res. Commun. 46:1972;1175-1180.
14. Nishi S., Matsue H., Yoshida H., Yamamoto R., Sakai M. Localization of the estrogen-binding site of alpha-fetoprotein in the chimeric human-rat proteins. Proc. Natl. Acad. Sci. USA. 88:1991;3102-3105.
15. Parmelee D.C., Evenson M.A., Deutsch H.F. The presence of fatty acids in human alpha-fetoprotein. J. Biol. Chem. 253:1978;2114-2119.
16. Hsia J.C., Er J.S., Tan C.T., Ester T., Ruoslahti E. α-Fetoprotein binding specificity for arachidonate, bilirubin, docosahexaenoate, and palmitate. A spin label study. J. Biol. Chem. 255:1980;4224-4227.
17. Ruoslahti E., Ester T., Seppälä M. Binding of bilirubin by bovine and human alpha-fetoprotein. Biochim. Biophys. Acta. 578:1979;511-519.
18. Aoyagi Y., Ikenaka T., Ichida F. Copper(II)-binding ability of human alpha-fetoprotein. Cancer Res. 38:1978;3483-3486.
19. Nagai M., Becker J.D., Deutsch H.F. The fatty acid levels of rat alpha-fetoprotein derived from fetuses, pregnancy and hepatoma sera. Oncodev. Biol. Med. 3:1982;343-350.
20. Lu C.Y., Changelian P.S., Unanue E.R. Alpha-fetoprotein inhibits macrophage expression of Ia antigens. J. Immunol. 132:1984;1722-1727.
21. Torres J.M., Laborda J., Naval J., Darracq N., Calvo M., Mishal Z., Uriel J. Expression of alpha-fetoprotein receptors by human T-lymphocytes during blastic transformation. Mol. Immunol. 26:1989;851-857.
22. King T.P., Spencer E.M. Amino acid sequences of the amino and the carboxyl terminal cyanogen bromide peptides of bovine plasma albumin. Arch. Biochem. Biophys. 153:1972;627-640.
23. Brown J.R. Structural origins of mammalian albumin. Fed. Proc. Fed. Am. Soc. Exp. Biol. 35:1976;2141-2144.
24. He X.M., Carter D.C. Atomic structure and chemistry of human serum albumin. Nature. 358:1992;209-211.
25. Peters T. Jr. Serum albumin. Adv. Protein Chem. 37:1985;161-245.
26. Pedersen K.O. An analysis of measured and calculated calcium quantities in serum. Scand. J. Clin. Lab. Invest. 38:1978;659-667.
27. Bradshaw R.A., Shearer W.T., Gurd F.R.N. Sites of binding of copper (II) ion by peptide (1-24) of bovine serum albumin. J. Biol. Chem. 243:1968;3817-3825.
28. Glennon J.D., Hughes D.W., Sarkar B. Nickel(II) binding to glycylglycyl-L-tyrosine-N-methyl amide, a peptide mimicking the NH2-terminal nickel(II)-binding site of dog serum albumin: a 1H- and 13C-nuclear magnetic resonance investigation. J. Inorg. Biochem. 19:1983;281-289.
29. Gurd F.R.N., Wilcox P.E. Complex formation between metallic cations and proteins, peptides and amino acids. Adv. Protein Chem. 11:1956;311-427.
30. 2+ binding by plasma proteins. Int. J. Pept. Protein Res. 5:1973;279-281.
31. Klopfenstein W.E. Thermodynamics of binding lysolecithin to serum albumin. Biochim. Biophys. Acta. 187:1969;272-274.
32. Spector A.A. Fatty acid binding to plasma albumin. J. Lipid Res. 16:1975;165-179.
33. Roda A., Cappelleri G., Clute O.L., Peters T. Jr. Quantitative aspects of the interaction of bile acids with human serum albumin. J. Lipid Res. 23:1982;490-495.
34. Savu L., Benassasyag C., Vallette G., Christeff N., Nunez E. Mouse alpha 1-fetoprotein and albumin. A comparison of their binding properties with estrogen and fatty acid ligands. J. Biol. Chem. 256:1981;9414-9418.
35. Jacobsen J. Studies of the affinity of human serum albumin for binding of bilirubin at different temperatures and ionic strength. Int. J. Pept. Protein Res. 9:1977;235-239.
36. Pearlman W.F., Crepy O. Steroid-protein interaction with particular reference to testosterone binding by human serum. J. Biol. Chem. 242:1967;182-189.
37. Unger W.G. Binding of prostaglandin to human serum albumin. J. Pharm. Pharmacol. 24:1972;470-477.
38. Sollene N.P., Wu H.-L., Means G.E. Disruption of the tryptophan binding site in the human serum albumin dimer. Arch. Biochem. Biophys. 207:1981;264-269.
39. Kragh-Hansen U. Molecular aspects of ligand binding to serum albumin. Pharmacol. Rev. 33:1981;17-53.
40. Sogami M., Foster J.F. Isomerization reactions of charcoal-defatted bovine plasma albumin. The N-F transition and acid expansion. Biochemistry. 7:1968;2172-2182.
41. Oliviery J.R., Craievich A.F. The subdomain structure of human serum albumin in solution under different pH conditions studied by small angle X-ray scattering. Eur. Biophys. J. 24:1995;77-84.
42. Wallevik K. Reversible denaturation of human serum albumin by pH, temperature, and guanidine hydrochloride followed by optical rotation. J. Biol. Chem. 248:1973;2650-2655.
43. Cooper A. Thermodynamic fluctuations in protein molecules. Proc. Natl. Acad. Sci. USA. 73:1976;2740-2741.
44. Tanford C. Protein denaturation. Adv. Protein Chem. 23:1968;121-282.
45. Uversky V.N. A multiparametric approach to studies of self-organization of globular proteins. Biochemistry (Moscow). 64:1999;250-266.
46. Žižkovský V., Štrop P., Korcáková J., Havranová M., Mikeš F. Fluorescence spectroscopy, fluorescence polarization, and circular dichroism in studies on pH-dependent changes in the α-fetoprotein molecule. Ann. New York Acad. Sci. 417:1983;49-56.
47. Kirkitadze M.D., Narizhneva N.V., Tomashevski A.Yu., Potekhin S.A., Uversky V.N. Stabilization of alpha-fetoprotein structure by sucrose. Bioorgan. Chem. (Moscow). 22:1996;408-414.
48. Uversky V.N., Kirkitadze M.D., Narizhneva N.V., Potekhin S.A., Tomashevski A.Yu. Structural properties of α-fetoprotein from human cord serum the protein molecule at low pH possesses all the properties of the molten globule. FEBS Lett. 364:1995;165-167.
49. Narizhneva N.V., Ivanova T.V., Tomashevski A.Yu., Uversky V.N. Comparison of structural properties of homologous proteins human serum albumin and α-fetoprotein. Mol. Biol. (Moscow). 31:1997;1128-1133.
50. Uversky V.N., Narizhneva N.V., Ivanova T.V., Tomashevski A.Yu. Rigidity of human a-fetoprotein structure is under the ligand control. Biochemistry. 44:1997;13638-13645.
51. Tomashevski A.Yu., Narizhneva N.V., Melnik T.N., Uversky V.N. α-Fetoprotein structure depends on the protein purification procedure: further evidence on the structure-forming role of the ligands. Protein Pept. Lett. 5:1998;295-301.
52. A.Yu. Tomashevski, T.N. Melnik, N.V. Narizhneva, M.M. Shavlovsky, V.B. Vasiliev, V.N. Uversky, The α-fetoprotein molecule has one or two rigid domains depending on the protein purification procedure, Protein Pept. Lett. 6, in press.
53. Luft A.J., Lorscheider F.L. Structural analysis of human and bovine α-fetoprotein by electron microscopy, image processing, and circular dichroism. Biochemistry. 22:1983;5978-5981.
54. Barker M.E. Evolution of alpha-fetoprotein: sequence comparisons among AFP species and with albumin species. Tumor Biol. 9:1988;123-136.
55. Gorin M.B., Cooper D.L., Eiferman F., van de Rijn P., Tilghman S.M. The evolution of alpha-fetoprotein and albumin. I. A comparison of the primary amino acid sequences of mammalian alpha-fetoprotein and albumin. J. Biol. Chem. 256:1981;1954-1959.
56. Dudich I., Tokhtamysheva N., Semenkova L., Dudich E., Hellman J., Korpela T. Isolation and structural and functional characterization of two stable peptic fragments of human alpha-fetoprotein. Biochemistry. 38:1999;10406-10414.
57. Alpert E., Drysdale J.W., Isselbacher K.J., Schur P.H. Isoelectric focusing of human fetoprotein: an aid in purification and characterization of microheterogeneity. J. Biol. Chem. 247:1972;3792-3798.
58. Yachnin S., Hsu R.C., Heinrikson R.L., Miller J.B. Studies on human alpha-fetoprotein. Isolation and characterization of monomeric and polymeric forms and amino-terminal sequence analysis. Biochim. Biophys. Acta. 493:1977;418-428.
59. Lester E.P., Miller J.B., Yachnin S. A postsynthetic modification of human alpha-fetoprotein controls its immunosuppressive potency. Proc. Natl. Acad. Sci. USA. 73:1977;4645-4648.
60. Gold P., Labitan A., Wong H.C.G., Freedman S.O., Krupey J., Shuster J. Physicochemical approach to the purification of human alpha1-fetoprotein from the ascites fluid of a hepatoma-bearing patient. Cancer Res. 38:1978;6-12.
61. Young J.L., Webb B.A. Two methods for the separation of human alpha-fetoprotein and albumin. (A) Affinity chromatography using Blue Sepharose CL-6B and (B) ampholyte displacement chromatography. Anal. Biochem. 88:1978;619-623.
62. Baig M.M. Purification of human α-fetoprotein. Anal. Biochem. 101:1980;200-203.
63. Sittenfeld A., Moreno E. A sensitive blotting system for detection of alpha-fetoprotein variants with monoclonal and polyclonal antibodies. J. Immunol. Methods. 106:1988;19-26.
64. Ruoslahti E., Seppälä M. Studies of carcino-fetal proteins: physical and chemical properties of human alpha-fetoprotein. Int. J. Cancer. 7:1971;218-225.
65. Auer I.O., Kress H.G. Suppression of the primary cell-mediated immune response by human alpha1-fetoprotein in vitro. Cell Immunol. 30:1977;173-179.
66. Hirai H., Nishi S., Watabe H. Alpha-fetoprotein. Tanpakushitsu Kakusan Koso. 18:1973;998-1005.
67. Yakimenko E.F., Karamova E.R., Goussev A.I., Hilgers J., Abelev G.I., Yazova A.K. Epitope mapping of human alpha-fetoprotein. Tumor Biol. 19:1998;301-309.
68. Abelev G.I., Karamova E.R., Lazarevich N.L., Kiseleva V.I., Poverenny A.M. Immunol. Lett. 40:1994;133-138.
69. Yazova A.K., Goussev A.I., Poltoranina V.S., Yakimenko E.F. Human alpha-fetoprotein epitopes as revealed by monoclonal antibodies. Immunol. Lett. 25:1990;325-330.
70. Karamova E.R., Yazova A.K., Goussev A.I., Yakimenko E.F., Abelev G.I. Conformational variants of human alpha-fetoprotein. Tumor Biol. 19:1998;310-317.
71. Strickland E.H. Aromatic contributions to circular dichroism spectra of proteins. CRC Crit. Rev. Biochem. 2:1974;113-175.
72. Privalov P.L. Stability of proteins. Small globular proteins. Adv. Protein Chem. 33:1979;167-241.
73. Ptitsyn O.B. Molten globule and protein folding. Adv. Protein Chem. 47:1995;83-229.
74. Privalov P.L., Potekhin S.A. Scanning microcalorimetry in studying temperature-induced changes in proteins. Methods Enzymol. 131:1986;4-51.
75. Privalov P.L. Stability of proteins. Proteins which do not present a single cooperative unit. Adv. Protein Chem. 35:1982;1-104.
76. Adler A.J., Greenfield N.J., Fasman G.D. Circular dichroism and optical rotatory dispersion of proteins and polypeptides. Methods Enzymol. 27:1973;675-735.
77. Uversky V.N., Narizhneva N.V., Ivanova T.V., Kirkitadze M.D., Tomashevski A.Yu. Ligand-free form of human a-fetoprotein: evidence for the molten globule state. FEBS Lett. 410:1997;280-284.
78. Endo T., Schatz G. Latent membrane perturbation activity of a mitochondrial precursor protein is exposed by unfolding. EMBO J. 7:1988;1153-1158.
79. Bychkova V.E., Ptitsyn O.B. The molten globule in vitro and in vivo. Chemtracts Biochem. Mol. Biol. 4:1993;133-163.
80. Ptitsyn O.B., Bychkova V.E., Uversky V.N. Kinetic and equilibrium folding intermediates. Phil. Trans. R. Soc. Lond. B. 348:1995;35-41.
81. Uversky V.N., Narizhneva N.V., Kirschstein S.O., Winter S., Löber G. Coformational transitions provoked by organic solvents in β-lactoglobulin: Can a molten globule-like intermediate be induced by the decrease in dielectric constant? Folding Design. 2:1997;163-173.
82. Eilers M., Endo T., Schatz G. Unfolding and refolding of a purified precursor protein during import into isolated mitochondria. EMBO J. 7:1988;1139-1145.
83. Van der Goot F.G., Gonzalez-Manas J.M., Lakkey J.H., Pattus F. A 'molten-globule' membrane-insertion intermediate of the pore-forming domain of colicin A. Nature. 354:1991;408-410.
84. Bychkova V.E., Berni R., Rossi G.-L., Kutyshenko V.P., Ptitsyn O.B. Retinol-binding protein is in the molten globule state at low pH. Biochemistry. 31:1992;7566-7571.
85. Bychkova V.E., Dujsekina A.E., Klenin S.I., Tiktopulo E.I., Uversky V.N., Ptitsyn O.B. Molten globule-like state of cytochrome c under conditions simulating those near the membrane surface. Biochemistry. 35:1996;6058-6063.
86. Kamatari Y.O., Konno T., Kataoka M., Akasaka K. The methanol-induced globular and expanded denatured states of cytochtome c: A study by CD, fluorescence, NMR and small-angle X-ray scattering. J. Mol. Biol. 259:1996;512-523.
87. Narizhneva N.V., Uversky V.N. Human α-fetoprotein is in the molten globule state under conditions modeling protein environment near the membrane surface. Protein Pept. Lett. 4:1997;243-249.
88. London J., Skrzynia C., Goldberg M.E. Renaturation of Escherichia coli tryptophanase after exposure to 8 M urea. Evidence for the existence of nucleation centers. Eur. J. Biochem. 47:1974;409-415.
89. Clark A.H., Saunderson D.H.P., Sugget A. Infrared and laser-Raman spectroscopic studies of thermally-induced globular protein gels. Int. J. Pept. Protein Res. 17:1981;353-364.
90. Mitraki A., King J. Protein folding intermediates and inclusion body formation. BioTechnology. 7:1989;690-697.
91. De Young L.R., Fink A.L., Dill K. Aggregation of globular proteins. Accounts Chem. Res. 26:1993;614-620.
92. De Young L.R., Dill K., Fink A.L. Aggregation and denaturation of apomyoglobin in aqueous urea solutions. Biochemistry. 32:1993;3877-3886.
93. Oberg K., Chrunyk B.A., Wetzel R., Fink A.L. Native-like secondary structure in interleukin-1/b inclusion bodies by attenuated total reflectance FTIR. Biochemistry. 33:1994;2628-2634.
94. Fink A.L. Molten globules. Methods Mol. Biol. 40:1995;343-360.
95. Fink A.L. Compact intermediate states in protein folding. Annu. Rev. Biophys. Biomol. Struct. 24:1995;495-522.
96. Semisotnov G.V., Kihara H., Kotova N.V., Kimura K., Amemiya Y., Wakabayashi K., Serdyuk I.N., Timchenko A.A., Chiba K., Nikaido K., Ikura T., Kuwajima K. Protein globularization during folding. A study by synchrotron small-angle X-ray scattering. J. Mol. Biol. 262:1996;559-574.
97. Eliezer D., Chiba K., Tsuruta H., Doniach S., Hodson K.O., Kihara H. Evidence of an associative intermediate on the myoglobin folding pathway. Biophys. J. 65:1993;912-917.
98. Segel D.J., Uversky V.N., Fink A.L., Hodgson K.O., Doniach S. Transient dimer in the refolding kinetics of cytochrome c characterized by small angle X-ray scattering. Biochemistry. 38:1999;15352-15359.
99. 3-forms is accompanied by the formation of an intermediate state. Biochemistry (Moscow). 63:1998;470-475.
100. Uversky V.N., Fink A.L. Structural effect of association on protein molecules in partially folded intermediates. Biochemistry (Moscow). 63:1998;456-462.
101. Uversky V.N., Fink A.L. Structural properties of staphylococcal nuclease in oligomeric A-forms. Biochemistry (Moscow). 63:1998;463-469.
102. Uversky V.N., Segel D.J., Doniach S., Fink A.L. Association-induced folding in globular proteins. Proc. Natl. Acad. Sci. USA. 95:1998;5480-5483.
103. Uversky V.N., Karnoup A.S., Khurana R., Segel D.J., Doniach S., Fink A.L. Association of partially-folded intermediates of Staphylococcal nuclease induces structure and stability. Protein Sci. 8:1999;161-173.
104. Nagai M., Becker J.D., Deutsch H.F. The fatty acid levels of rat alpha-fetoprotein derived from fetuses, pregnancy and hepatoma sera. Oncodevel. Biol. Med. 3:1982;343-350.
105. Deutsch H.F. Some biological roles for α-fetoprotein-unsaturated fatty acid complexes. Ann. New York Acad. Sci. 417:1983;39-48.
106. Yachnin S., Lester E. Inhibition of human lymphocyte transformation by human alpha-foetoprotein (HAFP); comparison of foetal and hepatoma HAFP and kinetic studies of in vitro immunosuppression. Clin. Exp. Immunol. 26:1977;484-490.
107. Goeken N.E., Thompson J.S. Conditions affecting the immunosuppressive properties of human α-fetoprotein. J. Immunol. 119:1977;139-142.
108. Lester E.P., Miller J.B., Yachnin S. A postsynthetic modification of human α-fetoprotein controls its immunosuppressive potency. Proc. Natl. Acad. Sci. USA. 74:1977;3988-3992.
109. Yachnin S. The immunosuppressive properties of α-fetoprotein: A brief overview. Ann. New York Acad. Sci. 417:1983;105-107.
110. 1-fetoprotein in vitro. Cell Immunol. 30:1977;173-179.
111. L. Belange, F. Daguillard, W.I. Waithe, D. Dufour, in: W.H. Fishman, S. Sell (Eds.), Onco-Developmental Gene Expression, Academic Press, New York, 1976, pp. 329-335.
112. N.E. Goeken, J.S. Thompson, in: W.H. Fishman, S. Sell (Eds.), Onco-Developmental Gene Expression, Academic Press, New York, 1976, pp. 307-315.
113. J. Uriel, J. Laborda, J. Naval, M. Geuskens, in: G.J. Mizejewski. H.I. Jacobson (Eds.), Biological Activities of alpha1-fetoprotein. Vol. 2, CRC Press, Boca Raton, FL, 1989, pp. 103-117.
114. Uriel J., Faivre-Bauman A., Trojan J., Foiret D. Immunochemical demonstration of alpha-fetoprotein uptake by primary cultures of fetal hemisphere cells from mouse brain. Neurosci. Lett. 27:1981;171-175.
115. Villacampa M.J., Moro R., Naval J., Failly-Crepin C., Lampreave F., Uriel J. Alpha-fetoprotein receptors in a human breast cancer cell line. Biochem. Biophys. Res. Commun. 122:1984;1322-1327.
116. Villacampa M.J., Lampreave F., Calvo M., Naval J., Pineiro A., Uriel J. Incorporation of radiolabelled alpha-fetoprotein in the brain and other tissues of the developing rat. Dev. Brain Res. 12:1984;77-82.
117. Uriel J., Villacampa M.J., Moro R., Naval J., Failly-Crepin C. Uptake of radiolabelled α-fetoprotein by mouse mammary carcinomas and its usefulness in tumor scintigraphy. Cancer Res. 44:1984;5314-5319.
118. Naval J., Villacampa M.J., Goguel A.F., Uriel J. Cell-type-specific receptors for α-fetoprotein in a mouse T-lymphoma cell line. Proc. Natl. Acad. Sci. USA. 82:1985;3301-3305.
119. 3H-arachidonic acid bound to AFP by autoradiography in rat rhabdomyosarcoma cells. J. Cell. Physiol. 128:1986;389-396.
120. Uriel J., Naval J., Laborda J. α-Fetoprotein-mediated transfer of arachidonoic acid into cultured cloned cells derived from rat rhabdomyosarcoma. J. Biol. Chem. 262:1987;3579-3585.